Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group.

Journal of cardiovascular pharmacology - 1 Jan 1995

Watts G F

Abstract excerpt

The St. Thomas' Atherosclerosis Regression Study (STARS) showed that treatment of mild hypercholesterolemia with diet or diet plus cholestyramine favorably influences the course of coronary heart disease (CHD) over 3 years in middle-aged men. The study employed quantitative angiography to measure...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins B
Share to Coronary Disease
Share to ACE gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Peptidyl-Dipeptidase A

Share to Polymorphism, Genetic

Share to Promoter Regions, Genetic

Share to Treatment Outcome

Source

Identifiers

PMID: 8907209

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-8907209-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group.PMID 8907209Read ↗

Nutritional mechanisms that influence cardiovascular disease.Semantic proximity Read ↗

Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.Semantic proximity Read ↗

Associations between a Genetic Risk Score for Clinical CAD and Early Stage Lesions in the Coronary Artery and the Aorta.Semantic proximity Read ↗

Dietary macronutrients, genetic variation, and progression of coronary atherosclerosis among women.Semantic proximity Read ↗

Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene.Semantic proximity Read ↗

Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis.Semantic proximity Read ↗

Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy.Semantic proximity Read ↗

Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events.Semantic proximity Read ↗

Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.Semantic proximity Read ↗

Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).Semantic proximity Read ↗

Effects of intensive lipid lowering compared with moderate-intensity lipid lowering on coronary atherosclerotic plaque phenotype and major adverse cardiovascular events in adults with low to intermediate 10-year ASCVD risk (ILLUMINATION study): protocol for a multicentre, open-label, blinded-endpoint, randomised controlled trial.Semantic proximity Read ↗

Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.